NCT00439920 GIMEMA LAL 0496: High-dose Anthracycline in the Induction Regimen for the Treatment of Adult ALL. Status UNKNOWN Phase PHASE2
NCT00439296 ABT-751 With Chemotherapy for Relapsed Pediatric ALL Status TERMINATED Phase PHASE1/PHASE2
NCT00412243 Clofarabine and Cyclophosphamide Combination in Acute Lymphoblastic Leukemia Patients Status COMPLETED Phase PHASE1/PHASE2
NCT00411541 Pulses of Vincristine and Dexamethasone in BFM Protocols for Children With Acute Lymphoblastic Leukemia Status COMPLETED Phase PHASE4
NCT00390793 Combination Chemotherapy and Dasatinib in Treating Participants With Philadelphia Positive or BCR-ABL Positive Acute Lymphoblastic Leukemia. Status COMPLETED Phase PHASE2
NCT00378534 Methods to Enhance the Safety and Effectiveness of Stem Cell Transplants Status COMPLETED Phase PHASE2
NCT00376467 STI 571 (GLIVEC) in the Treatment of Adult Acute Lymphoblastic Leukemia Status COMPLETED Phase PHASE2
NCT00374933 Enhancing Graft vs Leukemia Via Delayed Ex-Vivo Co-Stimulated DLI After Non-Myeloablative Stem Cell Transplantation Status COMPLETED Phase PHASE1
NCT00368355 T Cell Depletion for Recipients of HLA Haploidentical Related Donor Stem Cell Grafts Status COMPLETED Phase PHASE2
NCT00349518 Study of Dasatinib in Imatinib Resistant or Intolerant Subjects With Chronic or Advanced Phase CML or Philadelphia Chromosome Positive ALL Status WITHDRAWN Phase PHASE2/PHASE3
NCT00346632 An Ascending Dose Study of KW-2449 in Acute Leukemias, Myelodysplastic Syndromes, and Chronic Myelogenous Leukemia Status TERMINATED Phase PHASE1
NCT00328237 Treatment of Hematologic Malignancies With Single-Unit or Double-Unit Cord Blood Transplantation Status UNKNOWN Phase PHASE2
NCT00315705 A Study of Clofarabine in Combination With Etoposide and Cyclophosphamide in Children With Acute Leukemias. Status COMPLETED Phase PHASE1/PHASE2
NCT00300664 A Randomized Trial of Human Growth Hormone (hGH) vs Placebo in Intensively Treated Haemato-Oncology Patients. Status COMPLETED Phase PHASE2/PHASE3
NCT00287105 Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children Status COMPLETED Phase PHASE2